Mohammad A M Momin
Overview
Explore the profile of Mohammad A M Momin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Strickler S, Farkas D, Momin M, Vargas L, Aladwani G, Hindle M, et al.
Pharm Res
. 2025 Feb;
42(2):365-384.
PMID: 39930310
Purpose: To improve the quality of aerosol delivery to infants, the iDP-ADS was advanced to include dual-prong nose-to-lung aerosol administration with a bifurcating interface, consistently monitor lung pressures and control...
2.
Jubaer H, Strickler S, Farkas D, Dalton C, Momin M, Dodson K, et al.
AAPS PharmSciTech
. 2025 Jan;
26(1):34.
PMID: 39821052
The administration of surfactant aerosol therapy to preterm infants receiving continuous positive airway pressure (CPAP) respiratory support is highly challenging due to small flow passages, relatively high ventilation flow rates,...
3.
Momin M, Farkas D, Hindle M, Hall F, DiBlasi R, Longest W
Pharm Res
. 2024 Sep;
41(9):1903.
PMID: 39237798
No abstract available.
4.
DiBlasi R, KenKnight H, Kontoudios N, Farkas D, Momin M, Hall F, et al.
Pharm Res
. 2024 Sep;
41(9):1827-1842.
PMID: 39237797
Purpose: Surfactant therapy incorporates liquid bolus instillation via endotracheal tube catheter and a mechanical ventilator in preterm neonates with respiratory distress syndrome (RDS). Aerosolized surfactants have generated interest and conflicting...
5.
Momin M, Farkas D, Hindle M, Hall F, DiBlasi R, Longest W
Pharm Res
. 2024 Aug;
41(8):1703-1723.
PMID: 39112775
Purpose: Improving the deep lung delivery of aerosol surfactant therapy (AST) with a dry powder formulation may enable significant reductions in dose while providing improved efficacy. The objective of Part...
6.
Pangeni R, Poudel S, Momin M, Farkas D, Dalton C, Hall F, et al.
Int J Pharm
. 2024 Jul;
662:124504.
PMID: 39053676
Pulmonary delivery of antibiotics is an effective strategy in treating bacterial lung infection for cystic fibrosis patients, by achieving high local drug concentrations and reducing overall systemic exposure compared to...
7.
Jubaer H, Thomas M, Farkas D, Kolanjiyil A, Momin M, Hindle M, et al.
J Aerosol Sci
. 2024 Jan;
175:106262.
PMID: 38164243
Pharmaceutical aerosol systems present a significant challenge to computational fluid dynamics (CFD) modeling based on the need to capture multiple levels of turbulence, frequent transition between laminar and turbulent flows,...
8.
Howe C, Momin M, Aladwani G, Strickler S, Hindle M, Longest W
Int J Pharm
. 2023 Jul;
643:123199.
PMID: 37406945
There is a current medical need for a dry powder aerosol delivery device that can be used to efficiently and consistently administer high dose therapeutics, such as inhaled antibiotics, surfactants...
9.
Aladwani G, Momin M, Spence B, Farkas D, Bonasera S, Hassan A, et al.
Int J Pharm
. 2023 Jun;
642:123138.
PMID: 37307962
The objective of this study was to explore the aerosolization performance of powders produced with different mesh nebulizer sources in the initial design of a new small-particle spray dryer system....
10.
Spence B, Longest W, Dutta R, Momin M, Strickler S, Hindle M
AAPS PharmSciTech
. 2022 Nov;
24(1):10.
PMID: 36451052
The objective of this study was to develop a new heated dryer system (HDS) for high efficiency lung delivery of nebulized aerosol and demonstrate performance with realistic in vitro testing...